1-naphthylamine has been researched along with Endometrioma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bundren, JC; Warnock, JK | 1 |
| Bundren, JC; Morris, DW; Warnock, JK | 1 |
1 trial(s) available for 1-naphthylamine and Endometrioma
| Article | Year |
|---|---|
Sertraline in the treatment of depression associated with gonadotropin-releasing hormone agonist therapy.
Topics: 1-Naphthylamine; Adult; Affect; Antidepressive Agents, Second-Generation; Antineoplastic Agents, Hormonal; Depression; Endometriosis; Female; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Psychiatric Status Rating Scales; Retrospective Studies; Sertraline | 1998 |
1 other study(ies) available for 1-naphthylamine and Endometrioma
| Article | Year |
|---|---|
Anxiety and mood disorders associated with gonadotropin-releasing hormone agonist therapy.
Topics: 1-Naphthylamine; Adult; Antidepressive Agents; Antineoplastic Agents, Hormonal; Anxiety Disorders; Depressive Disorder; Endometriosis; Female; Humans; Leuprolide; Sertraline | 1997 |